HOPE Trials by Quincy Bioscience

About HOPE Trials

The mission of HOPE Trials is to improve the quality of life for individuals suffering from a wide array of debilitating conditions linked by a common cause, a mismanagement of calcium at the cellular level. HOPE Trials research consists of a variety of human trials measuring the effect of apoaequorin, a new dietary supplement ingredient, on cognitive functioning and quality of life.

Quincy Bioscience has identified a unique compound, originating from a jellyfish, which helps to regulate intracellular calcium levels and alleviate the toxic effects of excess calcium in the brain. This protein, apoaequorin, has demonstrated neuroprotective properties in the research lab. Available in capsule form, apoaequorin has improved the quality of life for a significant number of individuals who take it as a daily supplement.

Calcium Connection

Calcium has a critical role in a number of vital cell activities including stimulating neurotransmitter releases, activating enzymes and regulating gene expression. Numerous investigators have linked a variety of medical conditions to ineffectual control of calcium levels.

While neurodegenerative disorders, inflammatory diseases, auto-immune conditions and endocrine disorders affect the body in different ways and have unique symptoms they often have a common denominator, a loss of the ability to closely regulate the excessive influx of calcium ions.

More Information

Learn more about current research we are conducting or will be recruiting for in the near future. If you know a family member or friend who might benefit from HOPE Trials, please share our site with them.